Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| §103 only | 1 (14%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOUGH, TIFFANY MAUREEN | 2 | 31.4% | +46.9% |
| VANHORN, ABIGAIL LOUISE | 1 | 47.0% | +22.0% |
| RYAN, DOUGLAS CHARLES | 1 | 40.3% | +50.7% |
| CORDAS, EMILY ANN | 1 | 50.4% | +58.1% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 47.6% | +50.0% |
| BYRNES, DAVID R | 1 | 77.9% | +22.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009231 | METHOD OF MANUFACTURING MICRODEVICES FOR LAB-ON-CHIP APPLICATIONS | CORDAS, EMILY ANN | 49d overdue |
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | — |
| 18273501 | CRISPR-ASSOCIATED BASED-EDITING OF THE COMPLEMENTARY STRAND | VANHORN, ABIGAIL LOUISE | — |
| 18176874 | CAS12A NICKASES | RYAN, DOUGLAS CHARLES | — |
| 17466516 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009231 | METHOD OF MANUFACTURING MICRODEVICES FOR LAB-ON-CHIP APPLICATIONS | CORDAS, EMILY ANN | 49d overdue |
| 17298916 | METHODS OF GENETICALLY ALTERING A PLANT NIN-GENE TO BE RESPONSIVE TO CYTOKININ | BYRNES, DAVID R | 19d |
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | — |
| 18273501 | CRISPR-ASSOCIATED BASED-EDITING OF THE COMPLEMENTARY STRAND | VANHORN, ABIGAIL LOUISE | — |
| 18176874 | CAS12A NICKASES | RYAN, DOUGLAS CHARLES | — |
| 17619773 | Type III CRISPR/Cas-based Diagnostics | BUCHANAN, BAILEY CHEYENNE | — |
| 17466516 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | — |
| Art Unit | Apps |
|---|---|
| 1651 | 2 |
| 1636 | 1 |
| 1635 | 1 |
| 1632 | 1 |
| 1682 | 1 |
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | 1651 | §101DP | Final Rejection | — | Pending | May 30, 2025 |
| 18273501 | CRISPR-ASSOCIATED BASED-EDITING OF THE COMPLEMENTARY STRAND | VANHORN, ABIGAIL LOUISE | 1636 | §103§112 | Final Rejection | — | Pending | Jul 20, 2023 |
| 18176874 | CAS12A NICKASES | RYAN, DOUGLAS CHARLES | 1635 | §102§112 | Non-Final OA | — | Pending | Mar 01, 2023 |
| 18009231 | METHOD OF MANUFACTURING MICRODEVICES FOR LAB-ON-CHIP APPLICATIONS | CORDAS, EMILY ANN | 1632 | §101§112 | Final Rejection | 49d overdue | Pending | Dec 08, 2022 |
| 17619773 | Type III CRISPR/Cas-based Diagnostics | BUCHANAN, BAILEY CHEYENNE | 1682 | §103 | Non-Final OA | — | Pending | Dec 16, 2021 |
| 17466516 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | 1651 | §103§112Other | Final Rejection | — | Pending | Sep 03, 2021 |
| 17298916 | METHODS OF GENETICALLY ALTERING A PLANT NIN-GENE TO BE RESPONSIVE TO CYTOKININ | BYRNES, DAVID R | 1662 | §112 | Non-Final OA | 19d | Pending | Jun 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial